Romiplostim for platelet recovery after cord blood transplant
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a drug called Romiplostim N01 to help platelet levels recover faster in people with blood cancers who have had a cord blood transplant. It may reduce the need for platelet transfusions and lower bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have a blood cancer and are scheduled for a cord blood transplant.
- You are physically active (ECOG score 0-2).
- You are willing to sign a consent form and follow the study rules.
- You are not pregnant or breastfeeding, and do not have a known allergy to Romiplostim.
- You do not have a history of serious blood clots, active infections like hepatitis B/C, HIV, or recent severe bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether avatrombopag can help your platelet count recover after a bone marrow transplant from an unrelated donor (UCBT) in certain bone marrow failure diseases. If platelets recover better, it may reduce risks related to low platelets after transplant.
This trial tests a drug called Romiplostim to help raise low platelet counts caused by leukemia treatment. It is for adults with leukemia whose platelets are below 50 and who may benefit from this therapy.
This trial tests if romiplostim, a drug that helps the body make platelets, can speed up platelet recovery after a special type of stem cell transplant from a half-matched donor. It may help reduce bleeding risk during the recovery period.
This trial compares two drugs, romiplostim and rhTPO, to help increase platelet counts after a stem cell transplant in people with MDS or aplastic anemia. The goal is to see which drug works better at reducing the need for platelet transfusions.
This trial tests a drug called romiplostim for patients whose platelet counts stay very low (below 30) for a long time after chemotherapy, even after other treatments have failed. The goal is to see if romiplostim can help raise your platelet count to a safer level.
This trial tests a drug called romiplostim (Nplate) for patients whose aplastic anemia—a rare blood disorder where the bone marrow stops making enough blood cells—didn't improve after cancer treatment and hasn't responded to other medications. The drug may help your bone marrow produce more blood cells.
Hear when a new Platelet Recovery After Umbilical Cord Blood Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.